StockData
Protagenic Therapeutics, Inc.new logo

Protagenic Therapeutics, Inc.new (PTIX) stock

PTIXOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$0.75+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.36MP/E –Yield –

Protagenic Therapeutics, Inc.new free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Protagenic Therapeutics, Inc.new's free cash flow for the twelve months ending Dec 31, 2023 was -$3.85M. For fiscal 2023 it was -$3.85M.

Annual free cash flow

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$3.85M–
FY2022Dec 31, 2022-$2.00M–
FY2014Jun 30, 2014-$791.00K–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2023CQ4 2023Dec 31, 2023-$1.24M–

More Protagenic Therapeutics, Inc.new figures

See a number that looks wrong?